Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine

Acta Haematologica

Volumn 105, Issue 2, 2001, Pages 106-108

  Tsatalas, Costas ^a,c   Margaritis, Dimitris ^a   Kaloutsi, Vasiliki ^b   Martinis, George ^a   Kotsianidis, Ioannis ^a   Bourikas, George ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Regional Hospital of Alexandroupolis   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE;

ADULT; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DYSPROTEINEMIA; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE; T CELL LYMPHOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIDARABINE;

EID: 0034941772     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046545     Document Type: Article

References (6)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. Lymphoma classification - From controversy to consensus; the REAL and WHO classification of lymphoid neoplasms
3. Angioimmunoblastic lymphadenopathy with dysproteinemia: Emphasis on pathogenesis and treatment
4. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine
5. Successful treatment with fludarabine in two cases of angioimmunoblastic lymphadenopathy with dysproteinemia
6. Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues